Eric Emanuel, MD
Urology · Greenbelt, MDNPI 1609868983
Payments from drug & device makers
Across 128 payments — averaging $60.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avyxa Pharma, LLC$4K
- Olympus America Inc.$586
- Johnson & Johnson$342
- Astellas Pharma US Inc$297
- Endo USA, Inc.$195
- Dendreon Pharmaceuticals LLC$172
- plus $2K from 29 others
What the payments were for
- Speaking & faculty fees$2,00026%
- Travel & lodging$1,89824%
- Food & beverage$3,18941%
- Education$1592%
- Other$5617%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avyxa Pharma, LLC | 7 | $4,414 |
| Olympus America Inc. | 2 | $586 |
| Johnson & Johnson(2 entities) | 21 | $342 |
| Astellas Pharma US Inc | 16 | $297 |
| Endo USA, Inc. | 4 | $195 |
| Dendreon Pharmaceuticals LLC | 7 | $172 |
| AbbVie(2 entities) | 8 | $168 |
| Sumitomo Pharma America, Inc. | 7 | $168 |
| Axonics, Inc. | 2 | $124 |
| Pfizer | 7 | $123 |
| Urogen Pharma, Inc. | 2 | $121 |
| Immunitybio, Inc. | 2 | $119 |
| Telix Pharmaceuticals | 3 | $104 |
| Boston Scientific | 4 | $87 |
| Coloplast | 2 | $82 |
| Endo Pharmaceuticals Inc. | 4 | $72 |
| Bayer | 3 | $69 |
| Myovant Sciences Inc. | 2 | $63 |
| Ferring Pharmaceuticals Inc. | 3 | $45 |
| Zyla Life Sciences, Inc. | 3 | $43 |
| Halozyme Inc | 2 | $41 |
| Progenics Pharmaceuticals, Inc. | 2 | $40 |
| Blue Earth Diagnostics | 2 | $39 |
| AstraZeneca | 1 | $35 |
| Urovant Sciences Inc | 2 | $34 |
| Teleflex LLC | 1 | $34 |
| Civco Medical Instruments | 1 | $32 |
| Verity Pharmaceuticals Inc. | 1 | $29 |
| Skeletal Dynamics Inc | 1 | $26 |
| Amgen | 1 | $23 |
| Medtronic | 1 | $21 |
| Antares Pharma, Inc. | 1 | $17 |
| Novartis | 1 | $17 |
| Tolmar Pharmaceuticals, Inc. | 1 | $14 |
| Laborie Medical Technologies Corp. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CYSTO-NEPHRO VIDEOSCOPE$561
- XIAFLEX$113
How this compares
$7,807 in reported general payments places this provider in the 60th percentile of 274 urology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 445 | $8,575 |
| Oxybutynin Chloride ErOxybutynin Chloride | 129 | $5,410 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 143 | $3,935 |
| Solifenacin Succinate | 12 | $590 |
| Finasteride | 27 | $416 |
| Oxybutynin Chloride | 14 | $368 |
| Bicalutamide | 13 | $325 |
| CefuroximeCefuroxime Axetil | 27 | $85 |
| Ciprofloxacin Hcl | 40 | $77 |
Paid to pharmacies, not to this prescriber.
Other urology in Greenbelt
- Jonah MurdockGreenbelt$23K
- Matthew AllawayCumberland$20.6M
- Ronald TutroneBaltimore$18.1M
- Mohamad AllafBaltimore$7.1M
- Max KatesBaltimore$1000K
- Benjamin LowentrittBaltimore$994K
- Rian DicksteinHanover$750K
- Laura GiustoOwings Mills$628K
- Kenneth LangerBaltimore$610K
- Arvin GeorgeBaltimore$518K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.